HGENQ
Price:
$0.0002
Market Cap:
$0
Humanigen, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies that prevent and manage an overactive immune response. At the forefront of its pipeline is lenzilumab, a monoclonal antibody designed to neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF) by binding to it. This drug has been investigated for mitigating the cytokine storm in COVID-19 patients, having successfully completed a Phase 3 trial. It is also currently being evaluated in a Phase 2/3 study supported by the NIH. Furthermore, lenzilumab's potential extends to various other conditions: it is being explored in conjunction with CD19-targeted CAR-T cell therapies and for several inf...[Read more]
Industry
Biotechnology
IPO Date
2013-01-31
Stock Exchange
OTC
Ticker
HGENQ
According to Humanigen, Inc.’s latest financial reports and current stock price. The company's current ROE is 199.39%. This represents a change of 668.41% compared to the average of 25.95% of the last 4 quarters.
The mean historical ROE of Humanigen, Inc. over the last ten years is 105.51%. The current 199.39% ROE has changed 88.98% with respect to the historical average. Over the past ten years (40 quarters), HGENQ's ROE was at its highest in in the September 2016 quarter at 2.44%. The ROE was at its lowest in in the March 2016 quarter at -1761.69%.
Average
105.51%
Median
85.83%
Minimum
-617.20%
Maximum
1.01%
Discovering the peaks and valleys of Humanigen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 299.79%
Maximum Annual ROE = 1.01%
Minimum Annual Increase = -605.51%
Minimum Annual ROE = -617.20%
| Year | ROE | Change |
|---|---|---|
| 2022 | 150.19% | -85.11% |
| 2021 | 1.01% | -605.51% |
| 2020 | -199.52% | -345.36% |
| 2019 | 81.32% | -45.06% |
| 2018 | 148.01% | 63.83% |
| 2017 | 90.35% | -85.36% |
| 2016 | 617.01% | -199.97% |
| 2015 | -617.20% | 299.79% |
| 2014 | -154.38% | 122.79% |
| 2013 | -69.29% | -379.85% |
The current ROE of Humanigen, Inc. (HGENQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
319.75%
5-year avg
237.72%
10-year avg
105.51%
Humanigen, Inc.’s ROE is less than Cantabio Pharmaceuticals, Inc. (0%), less than Neuropathix, Inc. (111.19%), less than QSAM Biosciences, Inc. (1.62%), less than NMC Health plc (0%), less than Navidea Biopharmaceuticals, Inc. (355.34%), greater than Diagnocure, Inc. (-110.73%), greater than Total Brain Limited (-104.70%), less than Gelesis Holdings, Inc. (31.43%), less than Rapid Therapeutic Science Laboratories, Inc. (5.89%), less than Generex Biotechnology Corporation (216.76%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $22.77K | |
| 111.19% | $28.14K | |
| 1.62% | $18.44K | |
| 0% | $2.09K | |
| 355.34% | $10.01K | |
| -110.73% | $21.52K | |
| -104.70% | $26.74K | |
| 31.43% | $7.33K | |
| 5.89% | $883.00 | |
| 216.76% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Humanigen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Humanigen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Humanigen, Inc.'s ROE?
How is the ROE calculated for Humanigen, Inc. (HGENQ)?
What is the highest ROE for Humanigen, Inc. (HGENQ)?
What is the 3-year average ROE for Humanigen, Inc. (HGENQ)?
What is the 5-year average ROE for Humanigen, Inc. (HGENQ)?
How does the current ROE for Humanigen, Inc. (HGENQ) compare to its historical average?